Drug · DIN 02466236
RYDAPT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 8, 2017; first marketed September 8, 2017.
- Drug Identification Number (DIN)
- 02466236
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Midostaurin L01EX10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MIDOSTAURIN | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 21, 2017: NOC 19563New Drug Submission (NDS)